Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44044651HTLV-1ENSG00000077092.20protein_codingRARBNoNo5915P10826
Q5QHG3
Q86UC5
TVIS44048782HTLV-1ENSG00000077092.20protein_codingRARBNoNo5915P10826
Q5QHG3
Q86UC5
TVIS44036417HTLV-1ENSG00000077092.20protein_codingRARBNoNo5915P10826
Q5QHG3
Q86UC5
TCGA Plot Options
Drug Information
GeneRARB
DrugBank IDDB00755
Drug NameTretinoin
Target IDBE0000206
UniProt IDP10826
Regulation Typeagonist
PubMed IDs15958702; 9160172
CitationsSteidl U, Schroeder T, Steidl C, Kobbe G, Graef T, Bork S, Pechtel S, Kliszewski S, Kuendgen A, Rohr UP, Fenk R, Schroeder M, Haase D, Haas R, Kronenwett R: Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera. Ann N Y Acad Sci. 2005 Jun;1044:94-108.@@Regazzi MB, Iacona I, Gervasutti C, Lazzarino M, Toma S: Clinical pharmacokinetics of tretinoin. Clin Pharmacokinet. 1997 May;32(5):382-402. doi: 10.2165/00003088-199732050-00004.
GroupsApproved; Investigational; Nutraceutical
Direct Classification
SMILESCC(C=CC1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
PathwaysRetinol Metabolism; Vitamin A Deficiency
PharmGKBPA164746900
ChEMBLCHEMBL38